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Background: The use of potentially inappropriate medications (PIMs) may pose more risks than benefits to patients
and is a major factor contributing to the likelihood of serious adverse drug reactions and negative health outcomes
among older patients.
Methods: A retrospective chart review was conducted in a tertiary care center in USA where home medications of the
older patients were reviewed and analyzed upon hospital admission over three months, from March till May 2016.
Inclusion criteria were age of 65 years and above, history of cardiovascular disease, and admission to the cardiology
service. The aim of our study was to determine the frequency and factors associated with PIMs, by applying the
updated Beers 2015 criteria.
Results: A total of 404 patients were included in the study and were taking a total of 4669 medications at home, an
average of 11.6 ± 4.5 medications per patient. The proportion of PIMS was 20% of all medications reported, with an
average of 2.4 PIM per patient, and 87.4% of patients were receiving at least one PIM. Significant association was found
between use of PIMs and number of home medications, female gender, and number and types of comorbidities.
Comorbidities associated with more PIMs were heart failure, atrial fibrillation/flutter, history of falls/fractures,
cerebrovascular accident, and depression. The most commonly prescribed PIMs were: drugs that may exacerbate or
cause syndrome of inappropriate antidiuretic hormone secretion or hyponatremia (29.7%), scheduled use of proton
pump inhibitors (PPIs) > 8 weeks in non-high-risk patients (11.3%), and benzodiazepines (8.1%).
Conclusions: A high prevalence of PIMs in older patients with cardiovascular disease was observed. Provider education
and detailed assessment of medication lists upon hospital admission by multidisciplinary teams can help in preventing
the use of PIMs.
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The elderly population is very fragile and prone to
medication-related problems as a result of multiple
chronic diseases and conditions, poly-pharmacy, and
age-related changes in the pharmacokinetics and
pharmacodynamics of drugs [1–4]. Consequently, the* Correspondence: marwantaha@yahoo.com
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may be challenging and a complex process, leading to
increased risk of inappropriate prescribing. In addition,
the elderly account for a substantial portion of all health
care resource use and medication costs which under-
score the importance of recognizing and preventing
drug-related problems in this population [5].
Potentially inappropriate medication (PIM) is defined
as “a drug in which the risk of an adverse event out-
weighs its clinical benefit, particularly when there is a
safer or more effective alternate therapy for the samele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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identify PIMs in the elderly, the most known and fre-
quently used being Beer’s criteria, developed by Mark
Beers, MD, in the United States in 1991. The American
Geriatrics Society has updated the “Beers Criteria for
Potentially Inappropriate Medication Use in Older
Adults” in 2015, which includes an explicit list of PIMs
best avoided in older adults and in those with certain
diseases or syndromes, drugs that should be prescribed
at reduced dosage or with caution or carefully moni-
tored, and select drug–drug interactions documented to
be associated with harms in older adults [7]. The Beers
2015 criteria were developed by a panel with recognized
expertise in geriatric medicine, nursing, pharmacy prac-
tice, research, and quality measures.
Numerous studies have examined the prevalence of
PIMs in the elderly worldwide; in the United States and
Canada, the prevalence ranged between 14% to 37%,
while in Europe it ranged between 23% and 43% [8].
The older population has multiple manifestations of
cardiovascular disease and most of the medications pre-
scribed to treat their cardiovascular diseases are taken
for a long period of time due to the chronic nature of
their diseases such as hypertension, coronary artery dis-
ease, heart failure, and atrial fibrillation/flutter. A careful
search of the available literature revealed few studies on
PIMs in patients with cardiovascular diseases. The ob-
jective of our study was to determine the frequency and
factors associated with potentially inappropriate home
medications in older patients with cardiovascular dis-
eases admitted to the cardiology service in a tertiary care
teaching center in USA, by applying the updated Beers
2015 criteria.
Methods
A retrospective chart review was conducted in a tertiary
care teaching center, Huntsville Hospital, Alabama,
USA, over a three month period, between March and
May 2016. Home medications of the older patients were
reviewed and analyzed upon hospital admission. Inclu-
sion criteria were age of 65 years and above, history of
cardiovascular disease, and admission to the cardiology
service. Data collected included, demographic data,
condition or disease causing hospital admission, comor-
bidities, serum creatinine values, height, and weight. Es-
timation of glomerular filtration rate was calculated
using the Cockroft-Gault formula. The updated Beers
2015 criteria were used to identify the PIMs among the
study participants. The study was approved by the
Institutional Review Board.
Data collected from medical records were recorded on
a spreadsheet and analyzed using SPSS version v23 (BM
SPSS Statistics for Windows, Version 23.0. Armonk, NY:
IBM Corp). Descriptive statistics was expressed as meanand standard deviations for numerical data, and frequen-
cies and percentages for categorical data. The total num-
ber of home medication was calculated by summing the
number of medication reported by each participant, and
the proportion of PIMs was determined by dividing the
total number of PIMs by the computed total. The preva-
lence of PIM was calculated at the patient level, where
the number of patients with at least one PIM was con-
sidered the numerator and the total number of patients
as the denominator. Numerical variables were assessed
for normal distribution by inspecting their histograms,
boxplots, Q-Q plots, as well as comparing means to me-
dians. A multivariate linear regression was used to esti-
mate the association of multiple factors/determinants
with the number of PIMs per patient. The linear coeffi-
cient, their corresponding standard errors and p-values
were reported. Statistical significance was declared at
p < 0.05.
Results
A total of 404 patients were admitted to the cardiology
service and met inclusion criteria during the study
period, of which 211 (52.2%) were males and 193
(47.8%) were females. The mean age was 76.6 ± 7.4 years
and at the time of hospital admission, patients had a
mean of 6.1 ± 2.4 comorbidities. Table 1 describes pa-
tient characteristics and Table 2 describes their comor-
bidities. Several comorbidities were documented in
patients, of which hypertension was the most common
(75.0%), followed by dyslipidemia (52.2%), coronary ar-
tery disease (49.5%), and heart failure (41.8%). Patients
were taking a total of 4669 medications at home; an
average of 11.6 ± 4.5 medications per patient. The pro-
portion of PIMs among home medications was 20%,
with an average of 2.4 PIM per patient, with 87.4% of pa-
tients receiving at least one PIM. Table 3 describes num-
ber of home medications and PIMs.
The most commonly prescribed PIMs were: drugs that
may exacerbate or cause syndrome of inappropriate anti-
diuretic hormone secretion (SIADH) or hyponatremia
(29.7%), followed by scheduled use of proton pump in-
hibitors (PPIs) > 8 weeks in non high-risk patients
(11.3%), benzodiazepines (8.1%), and cardiovascular
agents that should be avoided or dose reduced due to
varying levels of kidney function (6.9%) (Table 4).
Significant association was found between the number
of PIMs per patient and number of home medications,
female gender, and number of comorbidities. Where fe-
males were observed to have on average 0.4 more PIMs
than the males (beta = 0.399 SE = 0.135, p-value = 0.003).
The number of PIMs increases by a factor of almost 0.2
(beta = 0.178, p-value < 0.001) for every additional home
medication. Furthermore, comorbidities associated with
more PIMs were heart failure, atrial fibrillation/flutter,
Table 2 Number of types of comorbidities in the same
Comorbidities characteristics Number Percent
Number of comorbidities
1–3 45 11.1
4 74 18.3
5 64 15.8
6 54 13.4
7 61 15.1
8 45 11.1
9+ 61 15.1
Mean (SD) 6.1 (2.4)
Type of comorbidity
Hypertension 303 75.0
Dyslipidemia 211 52.2
Coronary artery disease 200 49.5
Heart failure 169 41.8
Atrial fibrillation/flutter 145 35.9
Diabetes mellitus 143 35.4
Chronic renal disease 115 28.5
COPD 84 20.8
Gastro-esophageal reflux disease 79 19.6
Hypothyroidism 78 19.3
Cancer 77 19.1
Benign prostatic hyperplasia 65 16.1
Arthritis 63 15.6
Cardiac valve disease 61 15.1
Cerebrovascular accident 52 12.9
Anemia 47 11.6
Peripheral vascular disease 47 11.6
Sleep apnea 39 9.7
Depression 37 9.2
Gout 35 8.7
Pulmonary hypertension 30 7.4
Anxiety 29 7.2
Asthma 26 6.4
Obesity 26 6.4
Dementia 25 6.2
GI bleed/ulcer 25 6.2
Deep venous thrombosis / pulmonary embolism 25 6.2
Neuropathy 24 5.9
Table 1 Patient characteristics
General characteristics Number Percent
Age (years)
65–69 83 20.5
70–74 89 22.0
75–79 86 21.3
80–84 82 20.3
85–89 40 9.9
90+ 24 5.9
Mean (SD) 76.6 ± 7.4
Total 404
Gender
Male 211 52.2
Female 193 47.8
Reason for admission
Rule out cardiac etiology 31.4 31.4
Decompensated heart failure 19.8 19.8
Acute coronary syndrome 16.9 16.9
Atrial fibrillation/flutter 10.6 10.6
Syncope 4.0 4.0
Bradycardia 3.2 3.2
Length of stay
1–2 days 93 23.5
3–4 days 129 32.6
5–6 days 69 17.4
≥ 7 days 105 26.5
Mean, Median 5.3, 4.0
Sheikh-Taha and Dimassi BMC Cardiovascular Disorders  (2017) 17:189 Page 3 of 6history of falls or fractures, cerebrovascular accident,
and depression. The largest increase in the number of
PIMs was for those with history of falls/fractures where
these patients were found to have on average more than
1 additional PIM as compared to the rest of the sample
(beta = 1. 275, p = 0.014) and depression with similar in-
crease (beta = 1.1 and p-value <0.001). The model ex-
plained 40% of the variation in the number of PIM
reported (Adj R2 = 04) (Table 5).
Discussion
To our knowledge, this is the first study to evaluate the
use of potentially inappropriate home medications
among patients with cardiovascular disease admitted to
a cardiology service. Inappropriate use of medications is
more likely to occur in older patients since they are
more likely to receive several medications concomitantly
due to chronic diseases, and/or multiple health prob-
lems. In addition, age-related changes in the pharmaco-
kinetics and pharmacodynamics of drugs can play a role
in inappropriate prescribing. In our study, patients weretaking an average of 11.6 medications at home and had a
mean of 6.1 comorbidities, at least one of which was a
cardiovascular disease. Our study suggests a very high
level of exposure to PIMs among older patients with car-
diovascular diseases according to the updated 2015
Beers criteria; the prevalence of PIMs among home
Table 3 Number of home medication and PIMs
Number Percent
Number of medications
0 2 0.5
1–5 33 8.2
6–7 42 10.4
8–9 49 12.1
10–11 79 19.6
12–13 81 20.0
14–15 47 11.6
16 + 71 17.6
Mean (SD) 11.6 (4.5)
Total number of home medications 4669
Number of PIMs
0 51 12.6
1 92 22.8
2 98 24.3
3 66 16.3
4 49 12.1
5 29 7.2
6 12 3.0
7 3 0.7
8 3 0.7
9 1 0.2
Mean (SD) 2.4 (1.7)
Total number of PIMs 953
Proportion of PIM over home medication:
Mean (SD)
20% (19.4)
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one PIM, with an average of 2.4 PIMs per patient. Beers
criteria PIMs have been found to be associated with
poor health outcomes, including confusion, falls, and
mortality [9, 10].
It would be very challenging to compare the results of
our study that involved patients with cardiovascular dis-
eases to other available studies knowing that the preva-
lence of PIMs varies substantially depending on the
measures and definitions used, as well as the characteris-
tics of the studied group of patients, including clinical
settings and type of comorbidities. Another factor caus-
ing a variation in the prevalence of PIMs among studies
could be the different prescribing habits in different
countries. Nevertheless, the results of our study are con-
sistent with those conducted in USA and Canada [8].
The most commonly prescribed PIMs in our study
were drugs that may exacerbate or cause SIADH or
hyponatremia (29.7%). According to Beers criteria, the
use of this category of medications is to be used withcaution in older adults (not to be avoided) and clinicians
are strongly advised to monitor sodium level closely
when starting or changing dosages of these medications.
The most commonly used medications that belong to
this category of PIMs in our study were the diuretics (a
total of 175 PIMs), followed by selective serotonin re-
uptake inhibitors (SSRIs), and serotonin and norepin-
ephrine reuptake inhibitors (SNRIs). The high use of di-
uretics is expected in our patients as 41.8% suffered
from heart failure, a condition that is commonly associ-
ated with fluid overload [11]. Furthermore, 16.4 of our
patients suffered from depression or anxiety which is an
indication for using SSRIs or SNRIs.
The unnecessary use of PPIs accounted for 11.3% of
the PIMs in our study. PPIs continue to be among the
most commonly used group of drugs in many countries
and many patients take them chronically without an in-
dicated diagnosis. It is important that prescribers care-
fully consider the use of PPIs in older adults and
monitor their continued use to prevent the unnecessary
cost, drug-drug interactions and side effects, including
risk of Clostridium difficile infection, bone loss, and
fractures [12].
Benzodiazepines were also among the most com-
monly prescribed PIMs. With aging, more elderly suf-
fer from insomnia, anxiety, and other psychiatric
disorders leading physicians to prescribe benzodiaze-
pines. The 2015 Beers criteria recommends the avoid-
ance of this class of medications in older adults due
to the increased risk of cognitive impairment, falls,
fractures, delirium, and motor vehicle crashes. Few
older patients and prescribers seem to be willing to
try non-pharmacologic therapy or other medications
instead of benzodiazepines.
Age-associated loss of kidney function is a well-known
fact and many cardiovascular medications including po-
tassium sparing diuretics and anticoagulants, specifically
novel oral anti-coagulants (NOACs), need dose adjust-
ment or should be avoided in patients with reduced kid-
ney function [13]. In our study 6.9% of the PIMs were
mostly attributed to NOACs followed by potassium
sparing diuretics (mostly spironolactone) in patients with
low creatinine clearance at which action was required.
There was a significant association between use of
PIMs and number of home medications, number of co-
morbidities, and female gender. Increase in the number
of comorbidities, which is expected with aging, necessi-
tates prescribing more drugs to patients which can lead
to more PIMs. Poly-pharmacy has been shown in several
studies to be associated with PIMs [14–16]. Further-
more, our findings that females have 0.4 PIM more than
males is consistent with other studies, a fact that deserves
further investigation [17–21]. While neither socioeco-
nomic status nor comorbidity explained sex differences in
Table 4 Most common PIMs among home medications
Common PIMs Number Percent
Drugs that may exacerbate or cause SIADH or hyponatremia (including diuretics, SSRIs, SNRIs, and antipsychotics) 283 29.7
Scheduled use of PPIs >8 weeks in non-high risk patients 108 11.3
Benzodiazepines 77 8.1
Cardiovascular agents that should be avoided or dose reduced due to varying levels of kidney function
(including NOACs and potassium sparing diuretics)
66 6.9
CNS and analgesic agents that should be avoided or dose reduced due to varying levels of kidney function
(including duloxetine, gabapentin, pregabalin, and tramadol)
53 5.6
Combination of opioid analgesics with ≥2 other CNS active agents 39 4.1
Anticholinergics 38 4.0
H2 antagonists that should be dose reduced due to varying levels of kidney function 29 3.0
Digoxin used as first line therapy for atrial fibrillation / flutter or heart failure or dose >0.125 mg/d 23 2.4
Chronic use of non-cyclooxygenase-selective NSAIDS 23 2.4
Skeletal muscle relaxants 23 2.4
CNS central nervous system, GI gastrointestinal, NSAIDs non-steroidal anti-inflammatory drugs, NOACs novel oral anticoagulants, PPI proton pump inhibitors, SIADH
syndrome of inappropriate antidiuretic hormone secretion, SNRIs serotonin and norepinephrine reuptake inhibitors, SSRIs selective serotonin re-uptake inhibitors
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play a role by some investigators [19, 21].
In our study, cardiovascular diseases associated with
more PIMs were heart failure, atrial fibrillation/flutter,
and cerebrovascular accident. This should alert cardiolo-
gists to carefully prescribe and monitor medications
commonly given to treat those conditions.
Strategies that were shown to be effective in reducing
the use of PIMs include provider education and detailed
assessment of home medication lists upon hospital admis-
sion by a multidisciplinary team, which involves geriatri-
cians and specialized clinical pharmacists [22–25]. Poly-
pharmacy should provoke attempts to stop unnecessary
medications and drugs that are prone to be prescribed in-
appropriately; CNS-active drugs, PPIs, NSAIDs, NOACs,
diuretics, and digoxin should be carefully evaluated and
monitored. This should be followed by proper medication
reconciliation upon hospital discharge.Table 5 Multivariate regression of factors associated with PIMs
Factors B Std. Error p-value
Gender (Female) 0.399 0.135 0.003
Number of home medications 0.178 0.015 <0.001
Heart failure 0.273 0.142 0.056
Atrial fibrillation/flutter 0.468 0.142 0.001
History of falls/fractures 1.275 0.517 0.014
Cerebrovascular accident 0.565 0.200 0.005
Thromboembolism 0.559 0.287 0.052
Depression 1.104 0.236 <0.001
Adjusted R2 = 40%
B: regression coefficient
R2: the coefficient of determinationOur study has several limitations. First, it was a retro-
spective study. Second, there was no individualized
evaluation of risk and benefit for every single patient.
The PIMs could have been prescribed due to poor toler-
ance of alternative medications or possibly to avoid cer-
tain drug-drug interactions. Third, our study was limited
to one hospital setting despite being ranked and recog-
nized among the best hospitals in America.
Conclusion
A high prevalence of PIMs in older patients with cardio-
vascular disease was observed. Provider education and
detailed assessment of medication lists upon hospital ad-
mission by multidisciplinary teams can help in prevent-
ing the use of PIMs and consequently, decrease the
potential for drug-drug interactions, risk of serious ad-
verse drug reactions, and hospitalization.
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